SymbolBGLC
NameBIONEXUS GENE LAB CORP
SectorHEALTH CARE
RegionAsia
IndustryMedical Specialities
AddressNO. 8 JALAN KERINCHI,THE VERTICAL BUSINESS SUITE II, UNIT 02, LEVEL 10, TOWER B, KUALA LUMPUR, 59200, Malaysia
Telephone+60 122126512
Fax
Email
Websitehttps://www.bionexusgenelab.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001737523
Description

BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The companys non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis.

Additional info from NASDAQ:
BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The companys non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis.

2026-08-14 21:20

Director Tan Lee Su-Leng 🟢 acquired 338.7K shares of BioNexus Gene Lab Corp (BGLC) Transaction Date: Aug 13, 2026 | Filing ID: 000349

Read more
2026-08-14 21:18

Director Bin Abdul Hamid Muhammad Azrul 🟢 acquired 32.3K shares of BioNexus Gene Lab Corp (BGLC) Transaction Date: Aug 13, 2026 | Filing ID: 000347

Read more
2026-08-14 21:17

Chong Set Fui 🟢 acquired 96.8K shares of BioNexus Gene Lab Corp (BGLC) Transaction Date: Aug 13, 2026 | Filing ID: 000346

Read more
2026-08-14 21:14

Director Low Jook Yuen 🟢 acquired 16.1K shares of BioNexus Gene Lab Corp (BGLC) Transaction Date: Aug 13, 2026 | Filing ID: 000345

Read more
2026-08-14 18:29

New Form SCHEDULE 13D - BioNexus Gene Lab Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001520138-26-000354 <b>Size:</b> 160 KB

Read more
2026-08-07 17:29

New Form 3 - BioNexus Gene Lab Corp <b>Filed:</b> 2026-08-07 <b>AccNo:</b> 0001520138-26-000322 <b>Size:</b> 4 KB

Read more
2026-07-31 18:04

New Form 3 - BioNexus Gene Lab Corp <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001520138-26-000295 <b>Size:</b> 4 KB

Read more
2026-07-31 18:02

New Form 3 - BioNexus Gene Lab Corp <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001520138-26-000294 <b>Size:</b> 4 KB

Read more
2026-07-28 18:30

(68% Neutral) BIONEXUS GENE LAB CORP (BGLC) Announces Business Combination

Read more
2026-07-28 13:00

BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit

Read more